Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Discussing the use of Cemdisiran in patients with Immunoglobulin A Nephropathy (IgAN)

Ticker(s): ALNY, REGN

Who's the expert?

Institution: Dallas Nephrology Associates

Practicing Clinical nephrologist at Dallas Nephrology Associates
Experienced in both Chronic Kidney Disease and Dialysis.
Manages 25 IgA patients

Interview Goal

The goal of this interview is to discuss the standard of care for patients with immunoglobulin A nephropathy (IgAN) and the use of Cemdisiran as a potential treatment

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.